RxDoctor Payments Data

Orr Barak, MD

Dermatopathology · Sinking Spring, PANPI 1811182470

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $253 of the $340 with a category attached, or 74.3%. 6 manufacturers reported payments, led by Organogenesis Inc. at 36.9% of the total. Reporting peaked in 2022 at $153 and has fallen 69.6% since, to $47 in 2025. That places this record below the midpoint for dermatopathology clinicians in PA, where the typical reported total is $353.

$340in general payments, 2019–2025

Across 11 payments — averaging $30.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$126
  • Sanofi-aventis U.S. LLC$72
  • Sanofi$55
  • E.r. Squibb & Sons, L.L.C.$47
  • Galderma Laboratories, L.p.$26
  • Pfizer$15

What the payments were for

  • Food & beverage$25374%
  • Education$8726%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$340 in reported general payments places this provider in the 45th percentile of 27 dermatopathology providers in Pennsylvania.

See all dermatopathology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$1,702,548
Medicare patients
10,213
Services billed
23,902

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Dipropionate44$2,495
Dapsone42$1,736
Triamcinolone Acetonide85$795
MethotrexateMethotrexate Sodium31$751
Mycophenolate Mofetil18$682
Doxycycline Hyclate28$440
Clobetasol Propionate13$307
Cephalexin103$182
Mometasone Furoate12$155
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$11

Paid to pharmacies, not to this prescriber.

Other dermatopathology in Sinking Spring

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →